Interventional Care

We notice that you are visiting us from . This site only services US-based visitors. Would you like to visit the site that is appropriate for your location?
PDI has been monitoring the COVID-19 pandemic (SARS-CoV-2) to provide you the most current information to help manage this outbreak. On March 13, 2020, the CDC updated their recommendations to refer to List N on the EPA website for EPA-registered disinfectants that have qualified under EPA’s emerging viral pathogens program for use against SARS-CoV-2. Per the EPA’s website, “List N includes products that meet the EPA’s criteria for use against SARS-CoV-2, the cause of COVID-19. This list includes products with emerging viral pathogen claims and those with human coronavirus claims.”
As of March 13, the following PDI products can be found on List N (Page 4 and Page 11) entitled Products with Emerging Viral Pathogens and Human Coronavirus claims for use against SARS-CoV-2:
Click here to access List N via PDF.